订阅小程序
旧版功能

FURTHER: A Global Study to Evaluate Furmonertinib in Patients with EGFR Mutant NSCLC Including Uncommon EGFR Mutations (FURMO-002).

Xiuning Le,Alexander I. Spira,Shirish M. Gadgeel,Jonathan W. Riess,Yan Yu,Yanqiu Zhao,Ying Cheng,Oscar Juan-Vidal,Bo Gao,Kiyotaka Yoh,Martin Forster,Satoru Kitazono,Hidetoshi Hayashi,David Planchard,Yong Jiang, Nichole Baio,Marcin Kowanetz,William Leung,Jerry Y. Hsu,Jie Wang

Journal of Clinical Oncology（2024）

引用 0|浏览78
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要